186 related articles for article (PubMed ID: 8774616)
21. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland.
Robak T; Błasińska-Morawiec M; Błoński J; Hellmann A; Hałaburda K; Konopka L; Kotlarek-Haus S; Potoczek S; Hansz J; Dmoszyńska A; Urasiński I; Zdziarska B; Dwilewicz-Trojaczek J; Hołowiecki J; Skotnicki AB
Eur J Haematol; 1999 Jan; 62(1):49-56. PubMed ID: 9918312
[TBL] [Abstract][Full Text] [Related]
22. Rituximab followed by cladribine in the treatment of heavily pretreated patients with indolent lymphoid malignancies.
Robak T; Smolewski P; Urbanska-Rys H; Gora-Tybor J; Blonski JZ; Kasznicki M
Leuk Lymphoma; 2004 May; 45(5):937-44. PubMed ID: 15291352
[TBL] [Abstract][Full Text] [Related]
23. 2-Chlorodeoxyadenosine in the treatment of relapsed/refractory chronic lymphoproliferative disorders.
Rondelli D; Lauria F; Zinzani PL; Raspadori D; Ventura MA; Galieni P; Birtolo S; Forconi F; Algeri R; Tura S
Eur J Haematol; 1997 Jan; 58(1):46-50. PubMed ID: 9020373
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and toxicity of 2-Chlorodeoxyadenosine (Cladribine)--2 h infusion for 5 days--as first-line treatment for advanced low grade non-Hodgkin's lymphoma.
Fridrik MA; Jäger G; Kienzer HR; Hausmaninger H; Oppitz P; Krieger O; Zabernigg A; Lang A; Neubauer M; Weidinger G; Schiller L; Seewann HL; Chott A; Linkesch W
Eur J Cancer; 1998 Sep; 34(10):1560-4. PubMed ID: 9893628
[TBL] [Abstract][Full Text] [Related]
25. 2-Chlorodeoxyadenosine activity in patients with untreated, indolent non-Hodgkin's lymphoma.
Saven A; Emanuele S; Kosty M; Koziol J; Ellison D; Piro L
Blood; 1995 Sep; 86(5):1710-6. PubMed ID: 7655003
[TBL] [Abstract][Full Text] [Related]
26. Intermittent infusion of cladribine (CdA) in previously treated patients with low-grade non-Hodgkin's lymphoma.
Liliemark J; Porwit A; Juliusson G
Leuk Lymphoma; 1997 Apr; 25(3-4):313-8. PubMed ID: 9168441
[TBL] [Abstract][Full Text] [Related]
27. 2-Chlorodeoxyadenosine (2-CdA) in the treatment of patients with relapsed chronic lymphocytic leukemia.
Krykowski E; Warzocha K; Robak T
Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):317-21. PubMed ID: 8744653
[TBL] [Abstract][Full Text] [Related]
28. 2-Chlorodeoxyadenosine (cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemia.
Robak T; Błasińska-Morawiec M; Błoński JZ; Dmoszyńska A
Leuk Lymphoma; 1999 Jun; 34(1-2):151-7. PubMed ID: 10350343
[TBL] [Abstract][Full Text] [Related]
29. 2-Chlorodeoxyadenosine (Cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and younger.
Robak T; Błoński JZ; Urbańska-Ryś H; Błasińska-Morawiec M; Skotnicki AB
Leukemia; 1999 Apr; 13(4):518-23. PubMed ID: 10214856
[TBL] [Abstract][Full Text] [Related]
30. Role of low-dose 2-CdA in refractory or resistant lymphoplasmocytic lymphoma.
Cervetti G; Galimberti S; Cecconi N; Caracciolo F; Petrini M
J Chemother; 2004 Aug; 16(4):388-91. PubMed ID: 15332715
[TBL] [Abstract][Full Text] [Related]
31. The place of cladribine in the treatment of chronic lymphocytic leukemia: a 10-year experience in Poland.
Robak T
Ann Hematol; 2005 Feb; 84(2):63-70. PubMed ID: 15558283
[TBL] [Abstract][Full Text] [Related]
32. 2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia.
Saven A; Lemon RH; Kosty M; Beutler E; Piro LD
J Clin Oncol; 1995 Mar; 13(3):570-4. PubMed ID: 7884417
[TBL] [Abstract][Full Text] [Related]
33. Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma.
Robak T; Smolewski P; Cebula B; Szmigielska-Kaplon A; Chojnowski K; Blonski JZ
Cancer; 2006 Oct; 107(7):1542-50. PubMed ID: 16948126
[TBL] [Abstract][Full Text] [Related]
34. Long-term survival following cladribine (2-chlorodeoxyadenosine) therapy in previously treated patients with chronic lymphocytic leukemia.
Juliusson G; Liliemark J
Ann Oncol; 1996 Apr; 7(4):373-9. PubMed ID: 8805929
[TBL] [Abstract][Full Text] [Related]
35. Re-treatment with cladribine-based regimens in relapsed patients with B-cell chronic lymphocytic leukemia. Efficacy and toxicity in comparison with previous treatment.
Robak T; Boński JZ; Kasznicki M; Góra-Tybor J; Hellmann A; Konopka L; Dmoszyńska A; Dwilewicz-Trojaczek J; Wołowiec D;
Eur J Haematol; 2002 Jul; 69(1):27-36. PubMed ID: 12270059
[TBL] [Abstract][Full Text] [Related]
36. 2'-Chlorodeoxyadenosine: evaluation of a novel predominantly lymphocyte selective agent in lymphoid malignancies.
Hickish T; Serafinowski P; Cunningham D; Oza A; Dorland E; Judson I; Millar BC; Lister TA; Roldan A
Br J Cancer; 1993 Jan; 67(1):139-43. PubMed ID: 8094003
[TBL] [Abstract][Full Text] [Related]
37. Purine analogs in the treatment of chronic lymphocytic leukemia.
Pott C; Hiddemann W
Leukemia; 1997 Apr; 11 Suppl 2():S25-8. PubMed ID: 9178834
[TBL] [Abstract][Full Text] [Related]
38. The effect of 2-h infusion of 2-chlorodeoxyadenosine (cladribine) with prednisone in previously untreated B-cell chronic lymphocytic leukaemia.
Robak T; Błasińska-Morawiec M; Błoński JZ; Krykowski E; Komarnicki M; Trepińska E; Kaźmierczuk M; Hansz J; Dmoszyńska A; Roliński J; Konopka L; Skotnicki AB; Nowak WS; Kotlarek-Haus S; Zdziarska B; Urasiński I
Eur J Cancer; 1997 Dec; 33(14):2347-51. PubMed ID: 9616280
[TBL] [Abstract][Full Text] [Related]
39. Fludarabine, cyclophosphamide and mitoxantrone in relapsed or refractory chronic lymphocytic leukemia and low grade non-Hodgkin's lymphoma.
Hendry L; Bowen A; Matutes E; Swansbury J; Catovsky D
Leuk Lymphoma; 2004 May; 45(5):945-50. PubMed ID: 15291353
[TBL] [Abstract][Full Text] [Related]
40. Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia.
Mulligan SP; Karlsson K; Strömberg M; Jønsson V; Gill D; Hammerström J; Hertzberg M; McLennan R; Uggla B; Norman J; Wallvik J; Sundström G; Johansson H; Brandberg Y; Liliemark J; Juliusson G;
Leuk Lymphoma; 2014 Dec; 55(12):2769-77. PubMed ID: 24524339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]